NPI registry status
Active
2026 NPPES data Otology & Neurotology Physician NPI 1215970314 M.D.
Verify on CMS → Myles Pensak, M.D.
Otology & Neurotology Physician in Cincinnati, Ohio.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 334 in Otology & Neurotology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
121
Medicare Part D claims · 63 beneficiaries · Otology & Neurotology Physician avg: 401
Generic prescribing
86%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
78.8/100
▼ 4 pts below national avg 83.1 · Above neutral
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Myles Pensak, M.D. reported a CMS MIPS final score of 78.8/100 - below the 83.1 national average - and filed 121 Medicare Part D claims in 2023.
- 78.8/100
- MIPS score · -4 vs avg
- 121
- Part D claims, 2023
- 86%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Myles Pensak, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
79 27th percentile higher than 27% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Myles Pensak, M.D. sits
This provider among otology & neurotology physician peers
Across the 133 otology & neurotology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Myles Pensak, M.D. writes more Part D claims than 17% of them and scores higher on MIPS quality than 44% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one otology & neurotology physician peer from a representative sample of 60; the gold marker is Myles Pensak, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Myles Pensak, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Myles Pensak, M.D.?
Near national averagePrimary specialty
Otology & Neurotology Physician
Medicare Part D claims
121 70% vs specialty avg
MIPS final score
78.8/100 4.3 pts vs avg
Specialty distribution in Ohio
How Otology & Neurotology Physician compares to other specialties among Ohio providers
Medicare quality performance, MIPS
Myles Pensak, M.D.'s 2023 MIPS final score plotted against the Otology & Neurotology Physician national average
- MIPS Final Score
- 78.8/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Otology & Neurotology Physician) - 78.8/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Myles Pensak, M.D. appears in the CMS NPPES registry as an Otology & Neurotology Physician provider holding M.D. credentials at 222 PIEDMONT AVE, Cincinnati, OH, 45219, with a listed phone of (513) 475-8400. NPI 1215970314 was issued on 06/14/2006.
Medicare Part D records for calendar year 2023 show 121 prescription claims written by this provider, covering 63 Medicare beneficiaries and totaling roughly $5K in drug spend, split 14% brand-name and 86% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 78.8/100 for the 2023 performance year (Quality 70.4, Cost 58.9), compared with the national average of 83.1.
Otology & Neurotology Physician is a narrow specialty nationwide, with 334 enrolled providers across 46 states and an average of 401 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1215970314 |
|---|---|
| Specialty | Otology & Neurotology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/14/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
78.7894
Final Score
Avg: 83.1
70.4288
Quality
58.8691
Cost
100
Promoting Interoperability
Reporting: Group practice
License & disciplinary context - Ohio OMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~48K Ohio medical licensees in 2023 - they are NOT specific to Myles Pensak, M.D.. To verify Myles Pensak, M.D.'s current license status, search the OMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
158
Total board actions, Ohio 2023
Across 154 cases
3.29
Actions per 1,000 licensees
Ohio statewide rate
probation
Most common action type
56 cases
OMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Ohio disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Myles Pensak, M.D. - brand share 14.0%
Otology & Neurotology Physician average
14% brand-name claims vs 86% generic, on 121 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
121
Total Claims
$5K
Total Drug Cost
63
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 157
- Total Day Supply
- 3,498
- Brand vs Generic
- 14% brand / 86% generic
- Brand Drug Cost
- $3K
- Generic Drug Cost
- $1K
Patient Demographics
- Average Patient Age
- 68.8 years
- Avg HCC Risk Score
- 1.05
- Gender Split
- 68% female / 32% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Myles Pensak, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Triamterene-Hydroc…
Triamterene-Hydrochlorothiazid
25 claims
- Methylprednisolone
Methylprednisolone
19 claims
- Diazepam
Diazepam
17 claims
- Meclizine Hcl
Meclizine Hcl
13 claims
- Fluticasone Propio…
Fluticasone Propionate
12 claims
| Drug | Claims |
|---|---|
| Triamterene-Hydrochlorothiazid Triamterene/Hydrochlorothiazid | 25 |
| Methylprednisolone | 19 |
| Diazepam | 17 |
| Meclizine Hcl | 13 |
| Fluticasone Propionate | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Otology & Neurotology Physician Overview
How Myles Pensak, M.D. fits within the Otology & Neurotology Physician landscape nationally.
334
Otology & Neurotology Physician Providers in US
46
States with Otology & Neurotology Physician
401
Avg Claims per Provider
Myles Pensak, M.D.'s 121 claims are below the specialty average of 401.
Nearby Otology & Neurotology Physician Providers in Ohio
Other clinicians with the same primary specialty enrolled in Ohio, drawn from the same CMS NPPES roster as Pensak.
Dr. Mark Bassim
M.D.
Cleveland, OH
Dr. Leonard Berenholz
M.D.
Warren, OH
Dr. Edward Doyle
M.D.
Cincinnati, OH
Dr. Robert Goldenberg
MD
Dayton, OH
Dr. Stanley Lesinski
MD
Cincinnati, OH
Compare Otology & Neurotology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Ohio medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Otology & Neurotology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Ohio
Frequently Asked Questions
What is Myles Pensak, M.D.'s specialty? ▼
Myles Pensak, M.D. specializes in Otology & Neurotology Physician and practices in Cincinnati, Ohio. Credentials: M.D..
How much does Myles Pensak, M.D. prescribe under Medicare Part D? ▼
In 2023, Myles Pensak, M.D. wrote 121 Medicare Part D claims totaling $5K in drug costs for 63 beneficiaries.
What is Myles Pensak, M.D.'s Medicare quality score? ▼
Myles Pensak, M.D. has a CMS MIPS Final Score of 78.8/100 (Quality: 70.4, Cost: 58.9). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Myles Pensak, M.D. located? ▼
Myles Pensak, M.D. is located at 222 PIEDMONT AVE, Cincinnati, OH, 45219. Phone: (513) 475-8400.
What is Myles Pensak, M.D.'s NPI number? ▼
Myles Pensak, M.D.'s National Provider Identifier (NPI) is 1215970314, issued on 06/14/2006.
Does Myles Pensak, M.D. prescribe more brand-name or generic drugs? ▼
Myles Pensak, M.D.'s prescribing is 14% brand-name and 86% generic drugs by claim count, with $3K in brand drug costs.
How many Otology & Neurotology Physician providers are there in the US? ▼
There are 334 Otology & Neurotology Physician providers across 46 states in the US. The average Otology & Neurotology Physician provider writes 401 Medicare Part D claims per year.
What drugs does Myles Pensak, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Myles Pensak, M.D.'s most frequently prescribed drugs include Triamterene-Hydrochlorothiazid, Methylprednisolone, Diazepam. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Myles Pensak, M.D. accept Medicare? ▼
Myles Pensak, M.D. appears in CMS Medicare data with 121 Part D claims and 63 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Myles Pensak, M.D.'s credentials? ▼
Myles Pensak, M.D.'s NPI is 1215970314 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.